Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference39 articles.
1. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications;Steffel;Circulation,2006
2. Novel anticoagulants: confused at a higher level?;Steffel;Kardiovaskuläre Medizin,2008
3. Oral anticoagulation: practical considerations for the practicing clinician;Steffel;Cardiovasc,2007
4. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Ansell;Chest,2004
5. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Hirsh;Chest,2008
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis;Frontiers in Surgery;2023-04-17
2. Dabigatran: Clinical correlation of drug and its dose with risk of stroke and bleeding;Perspectives in Clinical Research;2023
3. Rivaroxaban versus Aspirin in Prevention of Venous Thromboembolism: A Meta-Analysis of 9 Randomized Controlled Trials comprising 7,656 Patients;Thrombosis and Haemostasis;2019-07-31
4. Clinical and Economic Outcomes of New Oral Anticoagulants in Orthopaedics;Serbian Journal of Experimental and Clinical Research;2018-03-01
5. Novel oral anticoagulants in atrial fibrillation;Journal of Cardiovascular Medicine;2015-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3